Sign inJoin waitlistJoin the waitlist

Oladapo O Yeku

Hematology & Oncology · Massachusetts General Hospital

Credentials: · · · · · ·

History

Memorial Sloan Kettering Cancer Center
Until 2018
University of Pittsburgh Medical Center
Until 2014
Renaissance School of Medicine at Stony Brook University***
2012

Research

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
Nature Biotechnology · 2018 · 685 citations
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)
Journal of Clinical Oncology · 2022 · 358 citations
Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
Scientific Reports · 2017 · First of 5 authors · 348 citations

DS
David Spriggs
11 papers
Eric Rubin
10 papers
Joyce Liu
7 papers
Renier Brentjens
7 papers
Cesar Castro
6 papers
RP
Richard Penson
6 papers
Sara Bouberhan
5 papers
Ursula Matulonis
5 papers
Alexi Wright
4 papers
Carolyn Krasner
4 papers
Meghan Shea
4 papers
Panagiotis Konstantinopoulos
4 papers

Clinical trials

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
Principal investigator · Not yet recruiting · Phase 2
Massachusetts General Hospital
2027–2028
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
Principal investigator · Active not recruiting · Phase 2
Massachusetts General Hospital
2020–2028